| Literature DB >> 22919582 |
Ana S Ferreira1, Inês N Silva, Vítor H Oliveira, Raquel Cunha, Leonilde M Moreira.
Abstract
The genus Burkholderia comprises more than 60 species able to adapt to a wide range of environments such as soil and water, and also colonize and infect plants and animals. They have large genomes with multiple replicons and high gene number, allowing these bacteria to thrive in very different niches. Among the properties of bacteria from the genus Burkholderia is the ability to produce several types of exopolysaccharides (EPSs). The most common one, cepacian, is produced by the majority of the strains examined irrespective of whether or not they belong to the Burkholderia cepacia complex (Bcc). Cepacian biosynthesis proceeds by a Wzy-dependent mechanism, and some of the B. cepacia exopolysaccharide (Bce) proteins have been functionally characterized. In vitro studies showed that cepacian protects bacterial cells challenged with external stresses. Regarding virulence, bacterial cells with the ability to produce EPS are more virulent in several animal models of infection than their isogenic non-producing mutants. Although the production of EPS within the lungs of cystic fibrosis (CF) patients has not been demonstrated, the in vitro assessment of the mucoid phenotype in serial Bcc isolates from CF patients colonized for several years showed that mucoid to non-mucoid transitions are relatively frequent. This morphotype variation can be induced under laboratory conditions by exposing cells to stress such as high antibiotic concentration. Clonal isolates where mucoid to non-mucoid transition had occurred showed that during lung infection, genomic rearrangements, and mutations had taken place. Other phenotypic changes include variations in motility, chemotaxis, biofilm formation, bacterial survival rate under nutrient starvation and virulence. In this review, we summarize major findings related to EPS biosynthesis by Burkholderia and the implications in broader regulatory mechanisms important for cell adaptation to the different niches colonized by these bacteria.Entities:
Keywords: Burkholderia; biosynthesis; cepacian; cystic fibrosis; exopolysaccharide; mucoid variation; persistence; virulence
Mesh:
Substances:
Year: 2011 PMID: 22919582 PMCID: PMC3417362 DOI: 10.3389/fcimb.2011.00016
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293
Structural formula of the exopolysaccharide repeated units described in the literature.
| EPS/species | Structure | Observations | Reference |
|---|---|---|---|
| Cepacian (PS-II)/ | Environmental and clinical isolates; | Cerantola et al. ( | |
| PS-I/ | Clinical isolate | Cerantola et al. ( | |
| Levan/ | This strain produces an EPS mixture that includes levan | Cescutti et al. ( | |
| EPS A/ | Endophytic diazotrophic species | Mattos et al. ( | |
| EPS B/ | EPS B composed of a mixture of two polymers: cepacian and the octasaccharide polymer, differing by the presence of a terminal glycosyl residue | Hallack et al. ( | |
| EPS/ | One acetyl group per RU | Nimtz et al. ( | |
| EPS/ | Isolated from rhizosphere and important for soil aggregation | Vanhaverbeke et al. ( |
Main species from where different EPS were identified and relevant information associated with strain source or EPS characteristics is provided. Gal, galactose; Glc, glucose; GlcA, glucuronic acid; Man, mannose; Rha, rhamnose; Fru, fructose; Kdo, 3-deoxy-D-manno-2-octulosonic acid; 6dTal, 6-deoxy-talose; .
Figure 1Genes and proteins involved in cepacian biosynthesis. (A) Genetic organization of bce-I and bce-II clusters of genes encoding proteins involved in cepacian biosynthesis. With exception of B. xenovorans, B. phymatum, B. phytofirmans, B. graminis, Burkholderia sp. H160 and sp. CCGE 1003, in most of Burkholderia species, the two clusters are located approximately 155–314 kb apart in the genome. (B) Neighbor-joining phylogenetic tree of the deduced amino acid sequences of Bce predicted proteins from 16 strains of Burkholderia distributed by 14 species. The several Bce protein sequences of each species were concatenated and were aligned by CLUSTALX 2.0 using 1000 bootstrap replicates and sorted by TreeView 1.6.6. The clusters obtained allow the distinction of Bcc strains (group I) from non-Bcc strains having the bce genes clustered separately (group II) or together (group III) in their genomes. Scale: number of substitutions per site.
Figure 2Biosynthesis of the exopolysaccharide cepacian by . (A) Metabolic route toward the synthesis of the various activated sugar-nucleotide precursors required for cepacian repeat-unit biosynthesis. (B) Schematic representation of enzymes involved in cepacian biosynthesis. Repeat-units of the polymer are assembled on a isoprenoid lipid carrier, in the cytoplasmic side of inner membrane in a reaction initiated by the BceB enzyme and continued by the other glycosyltransferases BceG, BceH, BceJ, BceK, and BceR and putative acyltransferases BceO, BceS and BceU. The lipid-linked repeat-units are translocated across the inner membrane by the putative BceQ membrane protein. Polymerization occurs at the periplasmic face of the inner membrane and is dependent on another membrane protein, the putative polysaccharide polymerase, BceI. Wzy-dependent polymerization/export requires the activity of the BceF tyrosine kinase. BceD is a protein tyrosine phosphatase enzyme responsible for dephosphorylating BceF. BceE forms a channel structure for export of EPS chains to the outside. BceP, putatively involved in polysaccharide degradation, is depicted as associated to the outer membrane, as one of its possible locations. Glc, glucose; GlcA, glucuronic acid; Gal, galactose; Rha, rhamnose; Man, mannose; Fru, fructose; GDP, guanosine-5′-diphosphate; UDP, uridine-5′-diphosphate; PGM, phosphoglucomutase; UGP, UDP-glucose pyrophosphorylase; UGD, UDP-glucose dehydrogenase; UGE, UDP-glucose epimerase; PGI, phosphoglucose isomerase; PMI, phosphomannose isomerase; PMM, phosphomannomutase; GMP, GDP-D-mannose pyrophosphorylase; GRS, GDP-rhamnose synthase; ATP, adenosine-5′- triphosphate; ADP, adenosine-5′- diphosphate; YP, phosphorylated tyrosine residue; Pi, inorganic phosphate; IM, inner membrane; OM, outer membrane; PL, peptidoglycan layer.
Figure 3Roles of .
Figure 4Bacterial phenotypes displaying variation during .